Vendor review
Zhuoyue Biotechnology reviews
Zhuoyue Biotechnology reviews from 37 independent lab tests (Tirzepatide, Retatrutide and GHK-Cu): grade A, purity and fill accuracy. Is Zhuoyue Biotechnology legit? See what its vials showed.
Grade A37 independent lab tests0 peptides listedShips from China
What the lab tests show
37 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 6, 2026 | Retatrutide | 100 % | 49.141 mg of 40 mg (23 %) | Pass | View |
| Aug 12, 2026 | Retatrutide | 99.9 % | 9.04 mg of 10 mg (-10 %) | Pass | View |
| Aug 2, 2026 | Tirzepatide | 99.9 % | 32.8 mg of 30 mg (9 %) | Pass | View |
| Jul 23, 2026 | GHK-Cu | 99.9 % | 42.9 mg of 50 mg (-14 %) | Pass | View |
| Jul 14, 2026 | Tirzepatide | 99.9 % | 17.3 mg of 20 mg (-14 %) | Pass | View |
| Jul 13, 2026 | Tirzepatide | 40 mg | Fail | View | |
| Jun 16, 2026 | Retatrutide | 99.6 % | 9.9 mg of 10 mg (-1 %) | Pass | View |
| Jun 16, 2026 | Tirzepatide | 99.9 % | 17.7 mg of 20 mg (-12 %) | Pass | View |
| May 28, 2026 | Retatrutide | 10 mg | View | ||
| May 27, 2026 | TB-500 | 91.7 % | 6.28 mg of 10 mg (-37 %) | Pass | View |
| May 25, 2026 | Retatrutide | 99.6 % | 7.9 mg of 10 mg (-21 %) | Pass | View |
| May 8, 2026 | Tirzepatide | 99.9 % | 15.9 mg of 15 mg (6 %) | Pass | View |
| May 2, 2026 | Tirzepatide | 99.8 % | 59.7 mg of 30 mg (99 %) | Pass | View |
| Apr 30, 2026 | Retatrutide | 99.8 % | 21.1 mg of 20 mg (6 %) | Pass | View |
| Mar 25, 2026 | Tirzepatide | 5 mg | Fail | View | |
| Mar 25, 2026 | Tirzepatide | 99.9 % | 11.2 mg of 10 mg (12 %) | Pass | View |
| Mar 7, 2026 | Retatrutide | 99.8 % | 15.1 mg of 15 mg (1 %) | Pass | View |
| Mar 6, 2026 | Retatrutide | 99.9 % | 9.77 mg of 10 mg (-2 %) | Pass | View |
| Mar 4, 2026 | Tirzepatide | 98.97 % | 38.4 mg of 40 mg (-4 %) | Pass | View |
| Mar 4, 2026 | Tirzepatide | 99.07 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Mar 4, 2026 | Tirzepatide | 99.9 % | 18.6 mg of 15 mg (24 %) | Pass | View |
| Mar 4, 2026 | Tirzepatide | 98.18 % | 40.4 mg of 40 mg (1 %) | Pass | View |
| Feb 20, 2026 | Retatrutide | 99.8 % | 17.7 mg of 15 mg (18 %) | Pass | View |
| Feb 20, 2026 | GHK-Cu | 99.71 % | 90.6 mg of 100 mg (-9 %) | Pass | View |
| Feb 20, 2026 | GHK-Cu | 99.73 % | 110 mg of 100 mg (10 %) | Pass | View |
| Feb 13, 2026 | Tirzepatide | 99.9 % | 40.3 mg of 40 mg (1 %) | Pass | View |
| Feb 11, 2026 | Retatrutide | 99.9 % | 31.8 mg of 30 mg (6 %) | Pass | View |
| Feb 11, 2026 | GHK-Cu | 99.9 % | 91.5 mg of 100 mg (-9 %) | Pass | View |
| Feb 6, 2026 | TB-500 | 98.83 % | 11.8 mg of 10 mg (18 %) | Pass | View |
| Jan 29, 2026 | Tirzepatide | 99.9 % | 30.2 mg of 30 mg (1 %) | Pass | View |
| Jan 19, 2026 | Retatrutide | 88.42 % | 8.84 mg of 10 mg (-12 %) | Pass | View |
| Jan 19, 2026 | Retatrutide | 99.95 % | 14.6 mg of 15 mg (-3 %) | Pass | View |
| Jan 19, 2026 | GHK-Cu | 99.95 % | 93.1 mg of 100 mg (-7 %) | Pass | View |
| Jan 19, 2026 | Tirzepatide | 99.95 % | 15.3 mg of 15 mg (2 %) | Pass | View |
| Jan 19, 2026 | TB-500 | 75.49 % | 10.9 mg of 10 mg (9 %) | Pass | View |
| Nov 14, 2025 | Tirzepatide | 99.6 % | 10.99 mg of 5 mg (120 %) | Pass | View |
| Aug 21, 2025 | Retatrutide | 99.72 % | 19.6 mg of 20 mg (-2 %) | Pass | View |
What Zhuoyue Biotechnology sells
No current listings on record.
About Zhuoyue Biotechnology
Finnrick has tested 37 samples from Zhuoyue Biotechnology across 4 products.